Samphire Neuroscience is a London-based medtech startup building non-invasive wearables to treat menstrual pain.
BUPR ran a one-off campaign for Samphire Neuroscience around their $2.3M pre-seed raise, with the challenge of cutting through a crowded health and biotech funding landscape. We positioned them as a serious neurotech company — scientifically credible and consumer-ready — and locked in a TechCrunch exclusive that became a reference point for future coverage. The piece created lasting momentum, with Samphire cited in trend and roundup features well beyond the initial campaign window.
Loved working with BUPR – the team have been very comprehensive in their support, understood our product and mission deeply, and made sure we were able to reach the audiences that we cared about. Would recommend!
We work with ambitious B2B startups and scaleups across Europe to help them gain trust, credibility, and exposure
